Fenwick advised Pharmakon on the deal while Akin Gump advised Pharmakon Advisors. Pharmakon, an investor in non-dilutive debt for the life sciences industry and the investment…
Standard 1 Year Membership Required
You must be a Standard 1 Year member to access this content.
Already a member? Log in here
